{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451239229
| IUPAC_name = 2-methyl-3-[(2''Z'',6''E'',10''E'')-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthoquinone
| image = Menatetrenone.PNG
| alt = Structural formula of menatetrenone
| width = 260
| image2 = Menatetrenone molecule spacefill.png
| alt2 = Space-filling model of the menatetrenone molecule

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|menatetrenone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 863-61-6
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 5282367
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 27Y876D139
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00100
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 78277
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4445530

<!--Chemical data-->
| C=31 | H=40 | O=2 
| molecular_weight = 444.648 g/mol
| synonyms = <small>3-methyl-2-[(2''Z'',6''E'',10''E'')-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione</small>
|  smiles = CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = DKHGMERMDICWDU-GHDNBGIDSA-N
}}

'''Menatetrenone''' ([[International Nonproprietary Name|INN]]), also known as MK-4, is a [[vitamin K]] compound used as a [[hemostatic]] agent, and also as [[Combination therapy|adjunctive therapy]] for the pain of [[osteoporosis]]. Menatetrenone is one of the nine forms of [[Vitamin K2|vitamin K<sub>2</sub>]].<ref name="pmid17274493">{{cite journal |vauthors=Iwamoto J, Takeda T, Sato Y |title=Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis |journal=Nutr. Rev. |volume=64 |issue=12 |pages=509–17 |date=December 2006 |pmid=17274493 |doi= 10.1111/j.1753-4887.2006.tb00184.x|url=http://openurl.ingenta.com/content/nlm?genre=article&issn=0029-6643&volume=64&issue=12&spage=509&aulast=Iwamoto}}</ref>

MK-4 is produced via conversion of vitamin K<sub>1</sub> in the body, in the testes, pancreas and arterial walls.<ref>{{cite journal|first=Shearer MJ|author2=Newman P.|title=Metabolism and cell biology of vitamin K|journal=Thrombosis and Haemostasis|year=2008|pages=530–547|doi=10.1160/TH08-03-0147|last1=Shearer|pmid=18841274|volume=100}}</ref> While major questions still surround the biochemical pathway for the transformation of vitamin K<sub>1</sub> to MK-4, studies demonstrate the conversion is not dependent on gut bacteria, occurring in germ-free rats<ref>{{cite journal|last=Davidson|first=RT|author2=Foley AL |author3=Engelke JA |author4=Suttie JW |title=Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria1|journal=Journal of Nutrition|year=1998|volume=128|issue=2|pages=220–223|pmid=9446847}}</ref><ref>{{cite journal |vauthors=Ronden JE, Drittij-Reijnders MJ, Vermeer C, Thijssen HH |title=Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat|journal=Biochimica et Biophysica Acta (BBA) - General Subjects|year=1998|volume=1379|issue=1|pages=69–75|pmid=9468334|doi=10.1016/S0304-4165(97)00089-5}}</ref> and in parenterally-administered K<sub>1</sub> in rats.<ref>{{cite journal|last=Thijssen|first=HHW|author2=Drittij-Reijnders MJ|title=Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4|journal=British Journal of Nutrition|year=1994|volume=72|issue=3|pages=415–425|pmid=7947656|doi=10.1079/BJN19940043}}</ref><ref>{{cite journal|last=Will|first=BH|author2=Usui Y |author3=Suttie JW |title=Comparative Metabolism and Requirement of Vitamin K in Chicks and Rats|journal=Journal of Nutrition|year=1992|volume=122|issue=12|pages=2354–2360|pmid=1453219}}</ref> In fact, tissues that accumulate high amounts of MK-4 have a remarkable capacity to convert up to 90% of the available K<sub>1</sub> into MK-4.<ref>{{cite journal|last=Davidson|first=RT|author2=Foley AL |author3=Engelke JA |author4=Suttie JW |title=Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria|journal=Journal of Nutrition|year=1998|volume=128|issue=2|pages=220–223|pmid=9446847}}</ref><ref>{{cite journal|last=Ronden|first=JE |author2=Drittij-Reijnders M-J |author3=Vermeer C |author4=Thijssen HHW|title=Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat|journal=Biochimica et Biophysica Acta (BBA) - General Subjects|year=1998|volume=1379|issue=1|pages=69–75|pmid=9468334|doi=10.1016/S0304-4165(97)00089-5}}</ref>

MK-4 is marketed for the osteoporosis [[Indication (medicine)|indication]] in [[Japan]] by [[Eisai Co.]], under the trade name '''Glakay'''.

==See also==
* [[Vitamin K]]
* [[Phylloquinone]] (vitamin K<sub>1</sub>)

==References==
{{reflist}}

==External links==
* Product information: {{cite web | url = http://www.eisai.jp/medical/products/di/EPI/GLA_SC_EPI.pdf | title = Glakay |date=November 2009 | accessdate = 2012-01-10 | format = PDF | publisher = [[Eisai Co.]]}}

{{Spoken Wikipedia|MenatetrenoneA.ogg|2012-09-08}}

{{Vitamin}}
{{Prostanoidergics}}

[[Category:1,4-Naphthoquinones]]
[[Category:Diterpenes]]
[[Category:Vitamin K]]


{{gastrointestinal-drug-stub}}